Multi-Tracer PET Assessment of Primary Brain Tumors

NCT00813566 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Brain Tumors
Cancer

Interventions

DRUG: [18F]fluoro-2-deoxy-D-glucose (FDG)
DRUG: 3'-deoxy-3'-[18F]fluorothymidine (FLT)
DRUG: [15O]-H2O
DRUG: [11C]Acetate

Sponsor

University of Utah